Target intelligence / Profile preview

Ubiquitin carboxyl-terminal hydrolase 43 (USP43)

Target
USP43
Molecular classification
Enzyme, Deubiquitinating enzyme (DUB), Ubiquitin-specific protease
01

Overview

Ubiquitin carboxyl-terminal hydrolase 43 (USP43) is a member of the ubiquitin-specific protease family of deubiquitinating enzymes. It recognizes and hydrolyzes peptide bonds at the C-terminal glycine of ubiquitin, thereby generating monoubiquitin from polyubiquitin chains and processing ubiquitinated substrates. USP43 plays a key role in regulating the hypoxic response by associating with hypoxia-inducible factor 1-alpha (HIF-1α), facilitating its nuclear accumulation and the expression of HIF-1 target genes in a hypoxia- and phosphorylation-dependent manner. Mechanistically, USP43 associates with 14-3-3 proteins to support HIF-1α signaling, and while its enzymatic function as a DUB contributes, some non-catalytic functions are also observed. Additionally, USP43 is implicated in metastasis, where it is upregulated in a Ca_v2.2/calcium–NFAT2 axis, promoting invadopodia formation, extracellular matrix degradation, and tumor cell invasion through stabilization of cortactin in breast cancer. While no therapeutics directly targeting USP43 are currently described, its roles in hypoxia signaling and cancer metastasis make it a molecule of interest for future therapeutic development.

Other names
Ubiquitin-specific-processing protease 43ubiquitin specific peptidase 43deubiquitinating enzyme 43FLJ30626ubiquitin thioesterase 43ubiquitin thiolesterase 43
02

Mechanism of action

Deubiquitination of substrate proteins, Regulation of nuclear accumulation and chromatin association of HIF-1α (not solely dependent on enzymatic deubiquitination activity but also on protein–protein interactions with 14-3-3 proteins)

03

Biological functions

DeubiquitinationProcessing of polyubiquitin precursorsRegulation of HIF-1 signalingFacilitation of HIF-1 nuclear accumulationRegulation of gene expression under hypoxiaCortactin stabilizationPromotion of invadopodia formationRegulation of cell migration and invasion
04

Disease associations

CancerHypoxia responseBreast cancer metastasisPotential roles in other hypoxia-driven diseases
05

Safety considerations

No specific safety or toxicity concerns documented for USP43 inhibition or modulation as a therapeutic targetDeubiquitinase inhibitors in general may affect multiple cellular pathways due to broad involvement in protein turnover and regulation
06

Biomarkers

Promoter of HIF-1 target gene expression in hypoxiaRegulator of cortactin stability and invadopodia in breast cancer (potential for biomarkers in metastasis, but no specific clinical biomarker established)

Beyond the preview

Go deeper on Ubiquitin carboxyl-terminal hydrolase 43 (USP43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 43 (USP43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call